James M. Gower

2014

In 2014, James M. Gower earned a total compensation of $1.4M as Former Chief Executive Officer, Chairman of the Board and Director at Rigel Pharmaceuticals, a 20% decrease compared to previous year.

Compensation breakdown

Option Awards$657,150
Salary$695,118
Other$9,906
Total$1,362,174

Gower received $695.1K in salary, accounting for 51% of the total pay in 2014.

Gower also received $657.2K in option awards and $9.9K in other compensation.

Rankings

In 2014, James M. Gower's compensation ranked 6,219th out of 13,032 executives tracked by ExecPay. In other words, Gower earned more than 52.3% of executives.

ClassificationRankingPercentile
All
6,219
out of 13,032
52nd
Division
Manufacturing
2,264
out of 4,966
54th
Major group
Chemicals And Allied Products
756
out of 1,686
55th
Industry group
Drugs
589
out of 1,365
57th
Industry
Pharmaceutical Preparations
450
out of 1,043
57th
Source: SEC filing on March 30, 2015.

Gower's colleagues

We found five more compensation records of executives who worked with James M. Gower at Rigel Pharmaceuticals in 2014.

2014

Donald Payan

Rigel Pharmaceuticals

Executive Vice President, of Discovery and Research

2014

Raul Rodriguez

Rigel Pharmaceuticals

Chief Executive Officer

2014

Elliott Grossbard

Rigel Pharmaceuticals

Chief Medical Officer

2014

Dolly Vance

Rigel Pharmaceuticals

General Counsel

2014

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

You may also like